Bruker (BRKR) EBITDA (2010 - 2026)

Bruker's EBITDA history runs 17 years deep, the most recent figure standing at $10.2 million for Q1 2026.

• Quarterly EBITDA fell 67.92% year-over-year to $10.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.6 million (down 78.83% YoY) and the FY2025 annual result came in at $68.2 million, down 73.05% from the prior year.
• EBITDA was $10.2 million for Q1 2026 at Bruker, down from $76.3 million in the prior quarter.
• Across five years, EBITDA topped out at $131.3 million in Q3 2022 and bottomed at -$51.8 million in Q3 2025.
• A 5-year average of $70.7 million and a median of $73.9 million in 2022 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2023 — EBITDA rose 27.15% — and 2025, when it plunged 176.06%.
• Bruker's EBITDA stood at $131.0 million in 2022, then dropped by 20.99% to $103.5 million in 2023, then plunged by 30.34% to $72.1 million in 2024, then climbed by 5.83% to $76.3 million in 2025, then sank by 86.63% to $10.2 million in 2026.
• Business Quant data shows BRKR's EBITDA at $10.2 million in Q1 2026, $76.3 million in Q4 2025, and -$51.8 million in Q3 2025.